Nestlé bolsters biopharmaceutical investments in diabetes and food allergy solutions

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

06 Mar 2020 --- In nutrition news this week, Nestlé Health Science expanded the international shipping of its personalized vitamin subscription program, Persona, to over 60... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

13 Feb 2020 --- Nestlé Health Science (NHSc)’s personalized nutrition service Persona Nutrition has added a new supplement in its portfolio that is touted as boosting... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

03 Feb 2020 --- Biopharmaceutical company Aimmune Therapeutics has received US Food and Drug Administration (FDA) approval for Palforzia, the first approved oral immunotherapy... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

07 Jan 2020 --- Atrium Innovations, a Nestlé Health Science (NHSc) company, has acquired technology-based functional medicine platform LivingMatrix in a bid to further... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

27 Sep 2019 --- Nestlé Health Science has invested in Before Brands, specialists in early childhood food allergy prevention, to forward initiatives to prevent rising allergy... Read More

trans